Phyllanthostatin IAlternative Names: NSC 328426; Phyllanthoside; Phyllanthostatin
Latest Information Update: 26 Oct 1994
$50 / €47 *
At a glance
- Originator National Cancer Institute (USA)
- Class Antineoplastics; Antivirals
- Mechanism of Action DNA synthesis inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 26 Oct 1994 NSC 328426's new name is phyllanthostatin I.